AU2009273911B2 - Methods for diagnosing and treating a heart condition in a patient - Google Patents

Methods for diagnosing and treating a heart condition in a patient Download PDF

Info

Publication number
AU2009273911B2
AU2009273911B2 AU2009273911A AU2009273911A AU2009273911B2 AU 2009273911 B2 AU2009273911 B2 AU 2009273911B2 AU 2009273911 A AU2009273911 A AU 2009273911A AU 2009273911 A AU2009273911 A AU 2009273911A AU 2009273911 B2 AU2009273911 B2 AU 2009273911B2
Authority
AU
Australia
Prior art keywords
patient
cartridge
gas
nitric oxide
air
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2009273911A
Other languages
English (en)
Other versions
AU2009273911A1 (en
Inventor
David H. Fine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vero Biotech Inc
Original Assignee
Vero Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vero Biotech Inc filed Critical Vero Biotech Inc
Publication of AU2009273911A1 publication Critical patent/AU2009273911A1/en
Application granted granted Critical
Publication of AU2009273911B2 publication Critical patent/AU2009273911B2/en
Assigned to VERO Biotech LLC. reassignment VERO Biotech LLC. Request to Amend Deed and Register Assignors: GENO LLC
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2009273911A 2008-07-24 2009-07-24 Methods for diagnosing and treating a heart condition in a patient Ceased AU2009273911B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8338608P 2008-07-24 2008-07-24
US61/083,386 2008-07-24
PCT/US2009/051695 WO2010011928A1 (en) 2008-07-24 2009-07-24 Methods for diagnosing and treating a heart condition in a patient

Publications (2)

Publication Number Publication Date
AU2009273911A1 AU2009273911A1 (en) 2010-01-28
AU2009273911B2 true AU2009273911B2 (en) 2016-09-08

Family

ID=41570625

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2009273911A Ceased AU2009273911B2 (en) 2008-07-24 2009-07-24 Methods for diagnosing and treating a heart condition in a patient

Country Status (6)

Country Link
US (1) US11000484B2 (cg-RX-API-DMAC7.html)
EP (2) EP2306814B1 (cg-RX-API-DMAC7.html)
JP (2) JP6058888B2 (cg-RX-API-DMAC7.html)
AU (1) AU2009273911B2 (cg-RX-API-DMAC7.html)
CA (2) CA2730011C (cg-RX-API-DMAC7.html)
WO (1) WO2010011928A1 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2257328A2 (en) * 2008-03-27 2010-12-08 Nellcor Puritan Bennett LLC Breathing assistance systems with lung recruitment maneuvers
EP2363163A1 (en) * 2008-03-27 2011-09-07 Nellcor Puritan Bennett LLC Device for controlled delivery of breathing gas to a patient using multiple ventilation parameters
WO2010011928A1 (en) 2008-07-24 2010-01-28 Geno Llc Methods for diagnosing and treating a heart condition in a patient
SI3498328T1 (sl) * 2009-05-27 2021-03-31 Mallinckrodt Hospital Products IP Limited Pripomoček za spajanje indeksiranega ventila in sestava posode pod tlakom s pritrdilnim obročem in za linearno sprožitev sestava sprožilnika pri odvajanju tekočin s pripomočkom za reguliranje dovajanja zdravila
EP2531249B1 (en) * 2010-02-01 2021-03-24 VERO Biotech LLC Nitric oxide delivery system
CA2797702C (en) * 2010-04-26 2020-03-10 VERO Biotech LLC. Delivery of ultra pure nitric oxide (no)
US8638200B2 (en) 2010-05-07 2014-01-28 Covidien Lp Ventilator-initiated prompt regarding Auto-PEEP detection during volume ventilation of non-triggering patient
US8607789B2 (en) 2010-06-30 2013-12-17 Covidien Lp Ventilator-initiated prompt regarding auto-PEEP detection during volume ventilation of non-triggering patient exhibiting obstructive component
US8607790B2 (en) 2010-06-30 2013-12-17 Covidien Lp Ventilator-initiated prompt regarding auto-PEEP detection during pressure ventilation of patient exhibiting obstructive component
US8607791B2 (en) 2010-06-30 2013-12-17 Covidien Lp Ventilator-initiated prompt regarding auto-PEEP detection during pressure ventilation
US8607788B2 (en) 2010-06-30 2013-12-17 Covidien Lp Ventilator-initiated prompt regarding auto-PEEP detection during volume ventilation of triggering patient exhibiting obstructive component
US8757153B2 (en) 2010-11-29 2014-06-24 Covidien Lp Ventilator-initiated prompt regarding detection of double triggering during ventilation
US8595639B2 (en) 2010-11-29 2013-11-26 Covidien Lp Ventilator-initiated prompt regarding detection of fluctuations in resistance
US8757152B2 (en) 2010-11-29 2014-06-24 Covidien Lp Ventilator-initiated prompt regarding detection of double triggering during a volume-control breath type
EP2645860A4 (en) 2010-12-03 2014-07-09 Geno Llc NITROGEN OXIDE TREATMENTS
US9038633B2 (en) 2011-03-02 2015-05-26 Covidien Lp Ventilator-initiated prompt regarding high delivered tidal volume
AU2012262534B2 (en) 2011-05-27 2016-06-02 VERO Biotech LLC. Method of determining vasoreactivity using inhaled nitric oxide
MX2014000095A (es) * 2011-07-07 2014-05-28 Janssen Diagnostics Llc Método de análisis de trastornos cardiovasculares y usos del mismo.
US20130145731A1 (en) * 2011-12-07 2013-06-13 Ecolab Usa Inc. Apparatus and method for configuring and opening product packaging
CN104411317A (zh) * 2012-03-15 2015-03-11 Ino治疗有限责任公司 用于施用高浓度一氧化碳的方法
US9027552B2 (en) 2012-07-31 2015-05-12 Covidien Lp Ventilator-initiated prompt or setting regarding detection of asynchrony during ventilation
TWI590837B (zh) * 2014-03-25 2017-07-11 林信湧 一種用於治療心臟病之吸入式醫藥組成物及其備製方法
JP6704094B2 (ja) 2017-02-27 2020-06-03 サード ポール, インコーポレイテッドThird Pole, Inc. 酸化窒素を生成するためのシステムおよび方法
MX2019009931A (es) 2017-02-27 2020-07-14 Third Pole Inc Sistemas y metodos para generacion ambulatoria de oxido nitrico.
MX2020010523A (es) 2017-02-27 2021-02-09 Third Pole Inc Sistemas y metodos para generar oxido nitrico.
US11672938B1 (en) 2018-07-18 2023-06-13 Vero Biotech LLC Start-up protocols for nitric oxide delivery device
US11754538B1 (en) * 2018-07-18 2023-09-12 Vero Biotech Inc. Method and apparatus for automatic calibration
WO2020232419A1 (en) 2019-05-15 2020-11-19 Third Pole, Inc. Systems and methods for generating nitric oxide
EP3969415A4 (en) 2019-05-15 2023-08-16 Third Pole, Inc. ELECTRODES FOR GENERATING NITROUS OXIDE
WO2020232414A1 (en) 2019-05-15 2020-11-19 Third Pole, Inc. Architectures for production of nitric oxide
EP4069069A4 (en) 2020-01-11 2024-07-03 Third Pole, Inc. SYSTEMS AND METHODS FOR NITROGEN OXIDE PRODUCTION WITH HUMIDITY CONTROL
EP4167920A4 (en) 2020-06-18 2024-06-12 Third Pole, Inc. Systems and methods for preventing and treating infections with nitric oxide
WO2022082072A1 (en) 2020-10-16 2022-04-21 Third Pole, Inc. Nitric oxide generation process controls
WO2023049873A1 (en) 2021-09-23 2023-03-30 Third Pole, Inc. Systems and methods for delivering nitric oxide
US12569628B2 (en) 2022-04-14 2026-03-10 Third Pole, Inc. Delivery of medicinal gas in a liquid medium

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165435A (en) * 1998-12-24 2000-12-26 Praxair Technology, Inc. Method and production of nitric acid
US20060048779A1 (en) * 2004-08-18 2006-03-09 Rounbehler David R Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
US20070148260A1 (en) * 2005-12-22 2007-06-28 Andre Denault Method for maintaining cerebral hemispheric oxygen saturation during surgery
US20070191478A1 (en) * 1999-09-08 2007-08-16 Duke University Methods of treating cardio pulmonary diseases with NO group compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5427797A (en) * 1993-04-06 1995-06-27 Brigham And Women's Hospital Systemic effects of nitric oxide inhalation
GB2279014B (en) * 1993-06-02 1997-07-16 Niall Keaney Device for controlling delivery of respiratory drugs
GB9320978D0 (en) * 1993-10-12 1993-12-01 Higenbottam Timohy W Nitric oxide treatment
US6063407A (en) * 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
WO2010011928A1 (en) 2008-07-24 2010-01-28 Geno Llc Methods for diagnosing and treating a heart condition in a patient

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165435A (en) * 1998-12-24 2000-12-26 Praxair Technology, Inc. Method and production of nitric acid
US20070191478A1 (en) * 1999-09-08 2007-08-16 Duke University Methods of treating cardio pulmonary diseases with NO group compounds
US20060048779A1 (en) * 2004-08-18 2006-03-09 Rounbehler David R Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
US20070148260A1 (en) * 2005-12-22 2007-06-28 Andre Denault Method for maintaining cerebral hemispheric oxygen saturation during surgery

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ADATIA, I. et al. The Journal of Thoracic and Cardiovascular Surgery, 1996, vol. 112, no. 5, ;pages 1403-1405. *
WESSEL, D.L. et al. Circulation, 1993, vol. 88, no. 5, pages 2128-2138. *

Also Published As

Publication number Publication date
US20100030091A1 (en) 2010-02-04
WO2010011928A1 (en) 2010-01-28
EP2687086B1 (en) 2016-09-14
EP2306814A4 (en) 2011-08-31
JP6058888B2 (ja) 2017-01-11
EP2687086A1 (en) 2014-01-22
EP2306814A1 (en) 2011-04-13
CA3037614A1 (en) 2010-01-28
EP2306814B1 (en) 2013-11-27
AU2009273911A1 (en) 2010-01-28
JP2015145376A (ja) 2015-08-13
JP2011529083A (ja) 2011-12-01
US11000484B2 (en) 2021-05-11
CA2730011C (en) 2019-05-07
CA2730011A1 (en) 2010-01-28

Similar Documents

Publication Publication Date Title
EP2687086B1 (en) Methods for diagnosing and treating a heart condition in a patient
US12059661B2 (en) Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
AU2008232413B2 (en) Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
US8246725B2 (en) Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
JP5567617B2 (ja) 二酸化窒素(no2)の酸化窒素(no)への変換
AU2013267074B2 (en) Conversion of Nitrogen Dioxide (NO2) to Nitric Oxide (NO)
AU2012244330A1 (en) Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
AU2015258294A1 (en) Conversion of Nitrogen Dioxide (NO2) to Nitric Oxide (NO)

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
HB Alteration of name in register

Owner name: VERO BIOTECH LLC.

Free format text: FORMER NAME(S): GENO LLC

MK14 Patent ceased section 143(a) (annual fees not paid) or expired